GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » R&G PharmaStudies Co Ltd (SZSE:301333) » Definitions » Accounts Receivable

R&G PharmaStudies Co (SZSE:301333) Accounts Receivable : ¥108.1 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is R&G PharmaStudies Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. R&G PharmaStudies Co's accounts receivables for the quarter that ended in Mar. 2024 was ¥108.1 Mil.

Accounts receivable can be measured by Days Sales Outstanding. R&G PharmaStudies Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 55.63.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. R&G PharmaStudies Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ¥14.35.


R&G PharmaStudies Co Accounts Receivable Historical Data

The historical data trend for R&G PharmaStudies Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R&G PharmaStudies Co Accounts Receivable Chart

R&G PharmaStudies Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.04 39.35 73.73 72.87 90.00

R&G PharmaStudies Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.65 112.07 90.17 90.00 108.12

R&G PharmaStudies Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


R&G PharmaStudies Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

R&G PharmaStudies Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=108.115/177.331*91
=55.63

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), R&G PharmaStudies Co's accounts receivable are only considered to be worth 75% of book value:

R&G PharmaStudies Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1699.125+0.75 * 108.115+0.5 * 63.011-431.176
-0-2.487)/96
=14.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


R&G PharmaStudies Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


R&G PharmaStudies Co (SZSE:301333) Business Description

Traded in Other Exchanges
N/A
Address
No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048
Website
R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

R&G PharmaStudies Co (SZSE:301333) Headlines

No Headlines